- Companies
- Noveris Health Sciences
Noveris Health Sciences Valuation Multiples
Noveris Health Sciences is valued at $1M as of November 2026. In the last fiscal year, Noveris Health Sciences EBITDA was $2M.
Noveris Health Sciences Overview
About Noveris Health Sciences
Noveris Health Sciences Inc, formerly Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Founded
2013
HQ
Employees
3
Website
Financials (Last FY)
EV
$923K
Valuation Multiples
Start free trialNoveris Health Sciences Financials
Noveris Health Sciences reported last fiscal year revenue of - and EBITDA of $2M.
In the same fiscal year, Noveris Health Sciences generated $2M in EBITDA and $2M in net income.
Noveris Health Sciences P&L
In the most recent fiscal year, Noveris Health Sciences reported revenue of - and EBITDA of $2M.
Noveris Health Sciences is profitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Noveris Health Sciences Stock Performance
Noveris Health Sciences has current market cap of $1M, and enterprise value of $923K.
Market Cap Evolution
Noveris Health Sciences' stock price is $0.02.
Noveris Health Sciences has an EPS (earnings per share) of $0.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $923K | $1M | -0.0% | - | - | - | $0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNoveris Health Sciences Valuation Multiples
Noveris Health Sciences trades at 0.4x EV/EBITDA.
Noveris Health Sciences Financial Valuation Multiples
As of November 19, 2026, Noveris Health Sciences has market cap of $1M and EV of $923K.
Noveris Health Sciences has a P/E ratio of 0.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Noveris Health Sciences Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Noveris Health Sciences Operational KPIs
Noveris Health Sciences' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Noveris Health Sciences Competitors
Noveris Health Sciences competitors include Respiratorius, Gabather, Geovax Labs, Biodexa Pharmaceuticals, Matinas BioPharma Holdings, Avenue Therapeutics, Bone Biologics, Cannovum Cannabis, Clearmind Medicine and PMGC Holdings.
Most Noveris Health Sciences public comparables operate across Nutraceuticals & Cosmeceuticals, Biopharmaceuticals and BioTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | ($350K) | - | - | (3.2x) | - | |||
| - | ($446K) | - | - | (1.7x) | (1.6x) | |||
| $2M | ($22M) | - | - | - | - | |||
| - | ($8M) | - | - | - | - | |||
| - | ($10M) | - | - | (0.0x) | - | |||
| $1M | ($3M) | - | - | - | - | |||
| - | ($3M) | - | - | - | - | |||
| - | ($447K) | - | - | (2.1x) | - | |||
This data is available for Pro users. Sign up to see all Noveris Health Sciences competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Noveris Health Sciences
Noveris Health Sciences has acquired 1 company to date.
Last acquisition by Noveris Health Sciences was on June 10th 2020. Noveris Health Sciences acquired NeuroPharm for $6M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Noveris Health Sciences
| Description | NeuroPharm was a Vancouver-based company developing evidence-based psychedelic-based therapies. Mydecine Innovations Group acquired it in an all-stock transaction that closed in 2020. |
| HQ Country | |
| HQ City | Vancouver |
| Deal Date | 10 Jun 2020 |
| Valuation | $6M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Noveris Health Sciences acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Noveris Health Sciences
| When was Noveris Health Sciences founded? | Noveris Health Sciences was founded in 2013. |
| Where is Noveris Health Sciences headquartered? | Noveris Health Sciences is headquartered in Canada. |
| How many employees does Noveris Health Sciences have? | As of today, Noveris Health Sciences has over 3 employees. |
| Is Noveris Health Sciences publicly listed? | Yes, Noveris Health Sciences is a public company listed on Canadian Securities Exchange. |
| What is the stock symbol of Noveris Health Sciences? | Noveris Health Sciences trades under NVRS ticker. |
| When did Noveris Health Sciences go public? | Noveris Health Sciences went public in 2014. |
| Who are competitors of Noveris Health Sciences? | Noveris Health Sciences main competitors include Respiratorius, Gabather, Geovax Labs, Biodexa Pharmaceuticals, Matinas BioPharma Holdings, Avenue Therapeutics, Bone Biologics, Cannovum Cannabis, Clearmind Medicine, PMGC Holdings. |
| What is the current market cap of Noveris Health Sciences? | Noveris Health Sciences' current market cap is $1M. |
| Is Noveris Health Sciences profitable? | No, Noveris Health Sciences is not profitable. |
| How many companies Noveris Health Sciences has acquired to date? | As of November 2026, Noveris Health Sciences has acquired 1 company. |
| What was the largest acquisition by Noveris Health Sciences? | $6M acquisition of NeuroPharm on 10th June 2020 was the largest M&A Noveris Health Sciences has done to date. |
| What companies Noveris Health Sciences acquired? | Noveris Health Sciences acquired NeuroPharm. |
| In how many companies Noveris Health Sciences has invested to date? | Noveris Health Sciences hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Noveris Health Sciences
Lists including Noveris Health Sciences
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




